About us Pricing ContactSubscribe

S

Sherene Loi

Uppsala University HospitalORCID https://orcid.org/0000-0001-6137-9171

h-index

—

Publications

—

Citations

—

i10-index

—

Impact (2-yr)

—

Top Publications

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

Annals of Oncology20143,065 citationsCorresponding

Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis

JNCI Journal of the National Cancer Institute20062,125 citations

Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial

The Lancet Oncology20161,795 citations

ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer

Annals of Oncology20211,287 citations

Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

Annals of Oncology20141,257 citationsFirst authorCorresponding

Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer

JNCI Journal of the National Cancer Institute20061,223 citations

Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series

Clinical Cancer Research2007981 citations

Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen

BMC Genomics2008405 citationsFirst authorCorresponding

Sherene Loi · Scinovex